News
October 3, 2012 — Royal Philips Electronics announced it is donating the one-millionth HeartStart automated external defibrillator (AED) manufactured to Everett Mountain Rescue Unit (EMRU) of Snohomish, Wash. EMRU is a volunteer search and rescue organization serving Snohomish County, also the location of Philips’ HeartStart headquarters.
October 03, 2012
News
October 3, 2012 — Sharp Memorial Hospital was the first on the West Coast to participate in Medtronic's SYMPLICITY HTN-3 clinical trial in March, and is currently the leading trial site in Southern California, to test an experimental medical device that aims to lower high blood pressure by using radio frequency energy to disrupt hyperactive nerves that contribute to the condition.
October 03, 2012
News
October 3, 2012 — Stentys, a medical technology company commercializing the world's first and only self-apposing stent to treat acute myocardial infarction (AMI), announced today the European commercial release of an enhanced stent-delivery system for its Self-Apposing stent.
October 03, 2012Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
News
October 2, 2012 — AstraZeneca has announced the results from a sub-analysis of PLATO that evaluated the effects of age on clinical outcomes in patients with acute coronary syndrome (ACS). Results of the analysis suggest the overall findings from the PLATO study of a greater reduction in thrombotic cardiovascular (CV) events with Brilinta (ticagrelor) tablets plus aspirin compared to clopidogrel plus aspirin were consistent regardless of age.
October 02, 2012
Technology
Terumo Cardiovascular Systems has announced the introduction of the VirtuoSaph Plus Endoscopic Vessel Harvesting System following clearance by the U.S. Food and Drug Administration (FDA).
October 02, 2012
News
October 2, 2012 — A new survey of physicians shows that if the U.S. presidential election were held today, 55 percent would vote for Mitt Romney and 36 percent would support President Barack Obama, according to a survey conducted by Jackson & Coker, a division of Jackson Healthcare, the third largest healthcare staffing company in the United States.
October 02, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa (dabigatran), has been rapidly adopted into clinical practice, yet thus far has had little impact on improving treatment rates for atrial fibrillation.
October 02, 2012
News
October 1, 2012 — Effective immediately, Ziehm Imaging, a market leader for mobile C-arms, is offering operating room (OR) tables from the Swedish manufacturer Stille to complement its Ziehm Vision RFD Hybrid Edition.
October 01, 2012
News
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the new drug application (NDA) resubmission for Eliquis (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).
October 01, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
October 1, 2012 — SunTech Medical’s One-Piece Durable Cuffs are a new line of easily disinfected, reusable cuffs for reliable blood pressure monitoring. The highly durable cuffs feature a cost-effective, one-piece design sturdy enough for repeated use in any clinical environment.
October 01, 2012
News
October 1, 2012 — CircuLite Inc. announced that the latest data from patients enrolled in the company’s CE mark trial of the Synergy Circulatory Support System strengthened prior findings indicating that implantation with Synergy resulted in significant, sustained improvements in hemodynamics and exercise tolerance.
October 01, 2012
Technology
September 28, 2012 — MindChild Medical Inc. announced that it has received 510(k) premarketing notification clearance from the U.S. Food and Drug Administration (FDA) for its Meridian noninvasive fetal heart monitor, and anticipates entering the U.S. market with Meridian soon. Additional pre-market regulatory filings are anticipated during 2012 and 2013.
September 28, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
September 28, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced the launch of its Quality Improvement and Value Assessment Program.
September 28, 2012
Feature
The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will revolutionize the stent industry. On Sept. 25, 2012, Abbott announced the launch of its drug-eluting bioabsorbable stent, Absorb, in Europe, the Middle East and parts of Asia Pacific and Latin America. Absorb, which received CE mark certification in 2011, is used to treat coronary artery disease. Bioabsorbable stents, such as Absorb, will broaden treatment and diagnostic options, reduce the need for long-term anti-platelet therapy and reduce the risk of in-stent restenosis and thrombosis.
September 28, 2012
Technology
September 28, 2012 — Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) clearance for the Emerge percutaneous transluminal coronary angioplasty (PTCA) balloon dilatation catheter, and has begun marketing the device in the United States.
September 28, 2012